Links
Organizations
Conferences
Info & Opinion
March 13, 2010
Fewer Features & Faster Setup
EDC, CTMS for Biotechs From ACS
ACS talks about a new product. The company is betting the combination of EDC and CTMS will appeal to biotech firms and contract research organizations.
Appeal In Biotech, CRO Sectors
A Challenger: The ClinPhone CTMS
Some customers invest in a clinical trial management system for better visibility into a trial. Others like owning their data for future projects.
Unified Interface By Next Year
ClinPhone’s ‘Compact,’ Adaptive Push
An expanding ClinPhone, with a headquarters in the UK and major offices in the U.S., talks about a new product and its overall strategy.
- Home
- Tag
- ctms
It had been a while. Years, actually. But Bruce Schatzman, president and CEO of Advanced Clinical Software (ACS) seems to be doing even better than we expected. He started the firm back in 1993. In our last conversation, published here a…
The clinical trial management system (CTMS) is a software Cinderella in the world of research. By dint of its modesty and centrality to the smooth operation of a trial, the CTMS should be a full-fledged member of the family of tools…
Parexel International’s technology division, Perceptive Informatics, announced an enhanced version of Impact, its clinical trial management system (CTMS). “As clients face further globalization of clinical trials and require site management and monitoring of increasingly complex studies, they need technology that keeps…
On the eve of the Drug Information Association (DIA) meeting next week, ClinPhone announced ClinPhone Compact. It’s a web-based tool, using the telephone and the internet, to manage patient randomization and drug supplies. To use the jargon, Compact is both an…
Tim Pratt cut his teeth in the world of medical devices, at Guidant and Medtronic, where a defibrillator can record 2,500 different variables. Fashioning a career out of working with such surging rivers of data, he landed at MedNet Solutions, where…
Global pharmaceutical companies are increasingly turning to Indian vendors offering drug discovery research using newer techniques at much lower costs. Major drug discovery companies are realizing that the question is no longer whether to outsource or not, but one of finding…
In an industry with so many seasoned people, why do so few trials finish on time and at budget? If we can send people into space, shouldn’t we know what it will cost to study a new antibiotic? ClearTrial may be…
Medifacts International announces the successful sale of its CRO division effective March 12, 2007. It is now operating as an independent provider of non-invasive cardiac safety and efficacy services (ABPM, Holter monitoring, ECG). Michael Woehler, Medifacts’ President and CEO said: “Medifacts…
